Search Press releases Keywords From To 31 Oct 2020 Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira[®] in Moderate-to-Severe Psoriasis Patients Read More 30 Oct 2020 Disposals of own shares Read More 29 Oct 2020 UCB Presents Nine Abstracts at EADV 2020, Showcasing Ongoing Commitment to Dermatology Read More 23 Oct 2020 Disposals of own shares Read More 22 Oct 2020 UCB’s anti-epileptic drug VIMPAT[®] (lacosamide) receives EU CHMP positive opinion for primary generalised tonic-clonic seizures Read More 16 Oct 2020 UCB FURTHER INVESTS IN UK OPERATIONS WITH AGREEMENT TO ACQUIRE A NEW LEADING-EDGE CAMPUS Read More Pagination First page Previous page Previous … Page 51 Page 52 Page 53 Page 54 Current page 55 Page 56 Page 57 Page 58 Page 59 … Page 55 of 66 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
